Healthcare M&A diligence and post-deal vendor consolidation, led from inside the work.
Healthcare M&A is unforgiving. The diligence questions that matter (clinical workflows, EHR compatibility, vendor lock-in, regulatory posture) are not the ones generalist M&A advisors ask. Our healthcare M&A practice is led by someone who has shaped product portfolios across BioReference, Nextech, and Pfizer, and who understands what a clinical-system decommissioning timeline actually looks like.
Operational and clinical-tech diligence: the questions that get missed when the deal team isn't from healthcare.
Post-deal vendor stacks are usually 2x what either side needs. We rationalize, with the clinical risk understood.
A practitioner takes the first call, never an SDR or a chatbot. 60 minutes, no obligation.